NEW YORK, Oct. 23, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 32 companies including many key and niche players such as - Abbott Diagnostics, Inc.AccuTech, LLCAlere Inc.Beckman Coulter, Inc.Chek Diagnostics
Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3A. Lipid Panel Test/Complete Lipid Profile I-3Total Cholesterol Test I-3HDL Cholesterol Test I-3LDL Cholesterol Testing I-3Triglycerides/VLDL Cholesterol Testing I-4B. Apolipoprotein B I-4C. Other Apolipoprotein Tests I-4
II. EXECUTIVE SUMMARY1. INDUSTRY OVERVIEW II-1Cholesterol Testing - An Overview II-1Current & Future Analysis II-2Increasing Healthcare Expenditure to Promote Testing Market II-2Table 1: Per-Capita Healthcare Expenditure in US$ for SelectRegions (2013) (includes corresponding Graph/Chart) II-3Developing Economies Offer Significant Potential II-3Table 2: Healthcare Spending as Percentage of GDP in SelectDeveloping Countries (2012) (includes correspondingGraph/Chart) II-4Table 3: Healthcare Spending as Percentage of GDP in SelectDeveloped Countries for 2004, 2008 & 2012 (includescorresponding Graph/Chart) II-42. TRENDS, DRIVERS & CHALLENGES II-5Global Menace of Cardiovascular Disease - Major Growth Factor II-5Table 4: Global Annual Medical Cost of CVD in US$ Billion(2010-2030) (includes corresponding Graph/Chart) II-5
Table 5: Fatalities by Heart Conditions - EstimatedPercentage Breakdown for Cardiovascular Disease, IschemicHeart Disease, Stroke, and Others (includes correspondingGraph/Chart) II-5Table 6: Fatalities in Low Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes corresponding Graph/Chart) II-6Table 7: Fatalities in Mid Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes corresponding Graph/Chart) II-7
Table 8: Fatalities in High Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD, Cancer, Injury, and Others(includes corresponding Graph/Chart) II-8Preventive Healthcare Trend to Expand Growth II-8Technological Advances to Improve Cholesterol Testing II-8Cholesterol Testing With Smartphone II-9Growing Smartphone Sales - A Business Case II-9Table 9: Top Ten Countries by Mobile Subscriptions inMillions (2012) (includes corresponding Graph/Chart) II-10Table 10: World Smartphone Market: Sales in Million Units byGeographic Region/Country for 2013 & 2017 (includescorresponding Graph/Chart) II-11Non-Invasive Cholesterol Tests to Drive Demand II-11Digital Photographs to Screen Cholesterol? II-11Miniature Sensors - The Future of Cholesterol Testing II-12Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers II-12The Rise of C-reactive Protein Tests II-13Global In-Vitro Diagnostics Market Signals Prospects II-13Table 11: Global In-Vitro Diagnostics Market by Test Category(2013): Percentage Breakdown of Value Sales for AnatomicPathology, Blood Screen Immunoassay, Coagulation, Hematology,Immunoassay, Microbiology, Molecular Diagnostics,Point-of-Care Diagnostics, and Others (includes correspondingGraph/Chart) II-14
Table 12: Global In-Vitro Diagnostics Market by Sector(2013): Percentage Breakdown of Revenues for Decentralized &Patient Self-Testing, and Hospital & Commercial Laboratories(includes corresponding Graph/Chart) II-15Table 13: Global Market for In-Vitro Diagnostics byGeographic Region (2013): Percentage Share Breakdown of ValueSales for Asia-Pacific (Excl. Japan), EMEA, Japan, LatinAmerica and North America (includes correspondingGraph/Chart) II-15Cardiac IVD Market Offers Potential II-15POC Testing: Potential Opportunities Ahead II-16Complexities in the POC Diagnostics Market II-16Aging Population - A Vital Demography for Cholesterol Testing II-16Table 14: Global Population Statistics for 65+ Age Group(Male & Female) for Major Countries/Regions (2013) (includescorresponding Graph/Chart) II-17
Table 15: Global Life Expectancy at Age 60 and 80 Years -(2010-2015), (2020-2025) & (2045-2050) (includescorresponding Graph/Chart) II-18Risk of CVD in Obesity Offers Prospects for Cholesterol Testing II-18Table 16: Global Obese Population in Millions by Region/Country (2013) (includes corresponding Graph/Chart) II-19Table 17: Global Obesity Levels (2013): Percentage ShareBreakdown of Total Obese Population by Leading Countries(includes corresponding Graph/Chart) II-20Diabetics at Higher Risk of Heart Diseases II-20Table 18: Worldwide Prevalence of Diabetes Mellitus byGeographic Region (2013 & 2035P) (includes correspondingGraph/Chart) II-21The Hypertension-Cholesterol Link to Drive Demand II-21Table 19: Death Rates Due to Hypertension in SelectCountries: 2011 II-22Table 20: Percentage Prevalence Rate of High Blood Pressurefor Patients over 25 Years of Age by Region (1980 & 2010)(includes corresponding Graph/Chart) II-24E-Retailing Drives Demand for Home Test Kits II-24Table 21: Factors Influencing Online Purchase Decision -Percentage Share Breakdown of Consumer Preferences byCriteria (includes corresponding Graph/Chart) II-253. AN INSIGHT INTO CARDIOVASCULAR DISEASES II-26The Heart of Heart Problems II-26Types of Cardiovascular Diseases/Disorders II-26Coronary Artery Disease II-26Hyperlipidemia - An Important Risk Factor of Heart Disease II-26Hypertension - The Silent Killer II-27Two-Pronged Approach to Counter CVD II-28Cardiovascular Risk Assessment II-28Reality Check II-28
4. GOOD & BAD OF CHOLESTEROL II-29Blood Cholesterol - The Principal Cardiac Risk Marker II-29Types of Cholesterol II-29Total Cholesterol (TC) II-29High Density Lipoprotein (HDL) II-29Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein(VLDL) II-30Triglycerides (TRG) II-30Glucose (GLU) II-30Alanine Aminotransferase (ALT) II-30Outcomes of High Blood Cholesterol II-30Atherosclerosis II-30Coronary Heart Disease (CHD) II-30Risk Factors and Risk Levels II-30Risk Factors II-30Risk Levels II-31Risk Level Based on Total Cholesterol Concentration II-31LDL-Cholesterol Risk Levels II-31HDL-Cholesterol Risk Levels II-31Triglyceride Risk Levels II-315. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES II-32Cholesterol Testing II-32Need for Cholesterol Testing II-32Candidates for Cholesterol Testing II-32Test Procedure II-33Time of Testing - Crucial for Heart Disease Patients II-33Types of Cholesterol Testing II-34Lipid Panel Test/Lipid Profile II-34Total Cholesterol Test II-34HDL Cholesterol Test II-35LDL Cholesterol Testing II-35LDL Cholesterol Test - The First Cholesterol Testing Method II-35Triglycerides/VLDL Cholesterol Testing II-36Apolipoprotein B Test II-36Other Cholesterol Tests II-36Apolipoprotein A-1 Test II-36ApoE Genotyping Test II-36Apolipoprotein CII II-36Other Key Markers for Cholesterol Testing II-37RLP Cholesterol II-37Non Instrumented Technologies II-37Heart Disease Diagnosis Tests II-37Non-Invasive Tests II-37Invasive Tests II-38Other CVD Markers II-38Creatine Kinase MB II-38Troponin T and Troponin I II-38Myoglobin II-39P-selectin Profile II-39C-reactive Protein II-39Endothelial Dysfunction II-40Homocysteine II-40Plasminogen Activator Inhibitor-1 II-40s-100 Protein II-41Thrombus Precursor Protein II-41Other Cardiac Markers II-41
6. POINT OF CARE & HOME CHOLESTEROL TESTING II-42Point of Care (POC) Medical Diagnostics II-42Table 22: Global Point of Care Diagnostics Market by Segment(2013): Percentage Breakdown of Revenues for Commercial Labs,Hospital Labs, Point of Care and Self Testing (includescorresponding Graph/Chart) II-42POC Testing Market II-43Table 23: Global Point-of-Care Diagnostics Market by POCTests (2013 & 2015): Percentage Share Breakdown of Revenuesfor Blood Chemistry, Cardiac Markers, Cholesterol, Drug &Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, andOthers (includes corresponding Graph/Chart) II-43Development of Home Cholesterol Testing Kits II-43Cholesterol and Other Cardiovascular Test Kits Offered bySelect Companies II-447. CHOLESTEROL CONTROL & TREATMENT MODALITIES II-45Prevention is better than Cure II-45Dietary Therapy II-45Healthy Diet II-45Exercises II-46Drug Therapy II-46Classification of Cholesterol Lowering Drugs II-46Bile Acid Sequestrants II-46Nicotinic Acid II-46HMG CoA Reductase Inhibitors (Statins) II-47Other Drugs (Fibric Acids and Probucol) II-47Testing After Commencing Drug Therapy II-478. PRODUCT INTRODUCTIONS/INNOVATIONS II-48CODIX Introduces SelexOn™ II-48Health Canada Approves Abbott's ARCHITECT STAT High SensitiveTroponin-I Assay II-48PTS Unveils CardioChek® Plus II-48ACON Introduces Mission® Systems II-48Everist Genomics to Unveil AngioDefender II-48Pathway Genomics Introduces InsightSM II-48Boston Heart Diagnostics Unveils SLCO1B1 Genotype Test II-48diaDexus Unveils PLAC® Test in Europe II-48
9. RECENT INDUSTRY ACTIVITY II-49PTS Switches Name to Chek Diagnostics II-49LipoScience Parts Ways with Health Diagnostics II-49Miraculins and Citizen Doctor Sign Distribution Deal II-49Akers Biosciences Signs Distribution Deal for Rapid Tests inAustralia, Singapore & Middle East II-49ITC Nexus Acquires Accumetrics II-49MedTest Signs Deal to Take Over Pointe Scientific II-49Response Biomedical Signs Deal for Sales Representation withMed Tech/Med Care II-49Corgenix Partners Health Diagnostic Laboratory II-50LipoScience Commences Clinical Development of NMR Diagnostics II-50Harbert Takes Over Cardioscan II-50BG Medicine Signs Deal with Kindstar Diagnostics to OfferGalectin-3 Testing Services II-5010. FOCUS ON SELECT PLAYERS II-51Abbott Diagnostics, Inc. (US) II-51AccuTech, LLC (US) II-51Alere Inc. (US) II-51Beckman Coulter, Inc. (US) II-52Chek Diagnostics (US) II-53F. Hoffmann-La Roche Ltd (Switzerland) II-53Home Access Health Corporation (US) II-54Siemens Healthcare (Germany) II-5411. GLOBAL MARKET PERSPECTIVE II-55Table 24: World Recent Past, Current & Future Analysis forCholesterol Testing by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual Tests inMillions for Years 2013 through 2020 (includes correspondingGraph/Chart) II-55
Table 25: World Historic Review for Cholesterol Testing byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-56Table 26: World 15-Year Perspective for Cholesterol Testing byGeographic Region - Percentage Breakdown of Tests for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) II-57Market by Test Type II-58Table 27: World Recent Past, Current & Future Analysis forLipid Panel/Complete Lipid Profile Tests by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets Independently Analyzedwith Annual Tests in Millions for Years 2013 through 2020(includes corresponding Graph/Chart) II-58Table 28: World Historic Review for Lipid Panel/ CompleteLipid Profile Tests by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual Tests inMillions for Years 2006 through 2012 (includes correspondingGraph/Chart) II-59
Table 29: World 15-Year Perspective for Lipid Panel/CompleteLipid Profile Tests by Geographic Region - PercentageBreakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-60Table 30: World Recent Past, Current & Future Analysis forApolipoprotein B Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualTests in Millions for Years 2013 through 2020 (includescorresponding Graph/Chart) II-61Table 31: World Historic Review for Apolipoprotein B Tests byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-62
Table 32: World 15-Year Perspective for Apolipoprotein B Testsby Geographic Region - Percentage Breakdown of Tests for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) II-63Table 33: World Recent Past, Current & Future Analysis forOther Cholesterol Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualTests in Millions for Years 2013 through 2020 (includescorresponding Graph/Chart) II-64Table 34: World Historic Review for Other Cholesterol Tests byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-65Table 35: World 15-Year Perspective for Other CholesterolTests by Geographic Region - Percentage Breakdown of Tests forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2006, 2014 &2020 (includes corresponding Graph/Chart) II-66
III. MARKET1. THE UNITED STATES III-1A.Market Analysis III-1Outlook III-1Surge in CVD Incidence - Major Growth Factor III-1Table 36: CVD in the US: Cardiovascular Disease Prevalencein Adults by Gender & Age Group (includes correspondingGraph/Chart) III-1Table 37: CVD in the US: Cardiovascular Disease Incidenceby Gender & Age Group (per 1,000 Adults) (includescorresponding Graph/Chart) III-2Table 38: Leading Causes of CVD Fatalities in the US:Percentage Breakdown of Mortality for Coronary HeartDisease, HBP, Heart Failure, Stroke, and Others (includescorresponding Graph/Chart) III-2Ageing Population - Vital Demography III-2Table 39: North American Elderly Population by Age Group:1975-2050 (includes corresponding Graph/Chart) III-3The Risk of CVD in Chronic Conditions to Drive Testing Market III-3Opportunity Indicators III-4Table 40: Obesity Prevalence in US Adults by Type ofObesity (2013) (includes corresponding Graph/Chart) III-4Table 41: Obesity Prevalence in the US by Age Group (2013)(includes corresponding Graph/Chart) III-4Table 42: Obesity Prevalence in the US by PercentageAnnual Income Level (2013) (includes correspondingGraph/Chart) III-4
Table 43: US Diabetics Population (2010-2017): PercentagePopulation with Diagnosed and Undiagnosed Diabetes(includes corresponding Graph/Chart) III-5Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart) III-5Table 45: High Blood Pressure Prevalence in the US (2012):Prevalence Rates for Male and Female Population by AgeGroups (includes corresponding Graph/Chart) III-6Table 46: High Blood Pressure Prevalence in the US (2012):Prevalence Rates for Male and Female Population by EthnicGroup (includes corresponding Graph/Chart) III-6Increasing Cardiovascular Ailments Drive Sales of Home TestDevices III-7Cholesterol POCT Market: An Overview III-7Cholesterol Testing - NCEP Recommendations Spurs Potential III-7Innovations Drive the Usage of Cardiovascular MonitoringSystems III-7Sterols and Stanols: Cholesterol-Lowering Products III-8Product Launches III-8Strategic Corporate Developments III-9Key Players III-10B.Market Analytics III-13Table 47: US Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-13
Table 48: US Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-14Table 49: US 15-Year Perspective for Cholesterol Testing byTest Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-15
2. CANADA III-16A.Market Analysis III-16Outlook III-16Product Launch III-16B.Market Analytics III-17Table 50: Canadian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-17Table 51: Canadian Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-18Table 52: Canadian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-19
3. JAPAN III-20Market Analysis III-20Table 53: Japanese Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-20Table 54: Japanese Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-21Table 55: Japanese 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-22
4. EUROPE III-23A.Market Analysis III-23Outlook III-23Product Launch III-23B.Market Analytics III-24Table 56: European Recent Past, Current & Future Analysisfor Cholesterol Testing by Geographic Region - France,Germany, Italy, UK, Spain, Russia, and Rest of EuropeMarkets Independently Analyzed with Annual Tests inThousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-24Table 57: European Historic Review for Cholesterol Testingby Geographic Region - France, Germany, Italy, UK, Spain,Russia, and Rest of Europe Markets Independently Analyzedwith Annual Tests in Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-25Table 58: European 15-Year Perspective for CholesterolTesting by Geographic Region - Percentage Breakdown of Testsfor France, Germany, Italy, UK, Spain, Russia, and Rest ofEurope Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-26
Table 59: European Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-27Table 60: European Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-28Table 61: European 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-29
4a. FRANCE III-30Market Analysis III-30Table 62: French Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-30Table 63: French Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-31Table 64: French 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-32
4b. GERMANY III-33A.Market Analysis III-33Outlook III-33Siemens Healthcare - Key German Player III-33B.Market Analytics III-34Table 65: German Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-34Table 66: German Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-35Table 67: German 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-36
4c. ITALY III-37Market Analysis III-37Table 68: Italian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-37Table 69: Italian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-38Table 70: Italian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-39
4d. THE UNITED KINGDOM III-40Market Analysis III-40Table 71: UK Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-40Table 72: UK Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-41Table 73: UK 15-Year Perspective for Cholesterol Testing byTest Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-42
4e. SPAIN III-43Market Analysis III-43Table 74: Spanish Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-43Table 75: Spanish Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-44Table 76: Spanish 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-45
4f. RUSSIA III-46Market Analysis III-46Table 77: Russian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-46Table 78: Russian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-47Table 79: Russian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-48
4g. REST OF EUROPE III-49A.Market Analysis III-49Outlook III-49Product Launch III-49F. Hoffmann-La Roche Ltd. - A Key Swiss Player III-49B.Market Analytics III-50Table 80: Rest of Europe Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-50Table 81: Rest of Europe Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-51Table 82: Rest of Europe 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-52
5. ASIA-PACIFIC III-53A.Market Analysis III-53The Largest Market Worldwide III-53B.Market Analytics III-54Table 83: Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Geographic Region -China, India, and Rest of Asia-Pacific Markets IndependentlyAnalyzed with Annual Tests in Thousands for Years 2013through 2020 (includes corresponding Graph/Chart) III-54Table 84: Asia-Pacific Historic Review for CholesterolTesting by Geographic Region - China, India, and Rest ofAsia-Pacific Markets Independently Analyzed with AnnualTests in Thousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-55Table 85: Asia-Pacific 15-Year Perspective for CholesterolTesting by Geographic Region - Percentage Breakdown of Testsfor China, India, and Rest of Asia-Pacific Markets for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-56Table 86: Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-57
Table 87: Asia-Pacific Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-58Table 88: Asia-Pacific 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-59
5a. CHINA III-60A.Market Analysis III-60Outlook III-60Corporate Development III-60B.Market Analytics III-61Table 89: Chinese Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-61Table 90: Chinese Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-62Table 91: Chinese 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-63
5b. INDIA III-64A.Market Analysis III-64Outlook III-64Corporate Development III-64B.Market Analytics III-65Table 92: Indian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-65Table 93: Indian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-66Table 94: Indian 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-67
5c. REST OF ASIA-PACIFIC III-68A.Market Analysis III-68Outlook III-68Corporate Development III-68B.Market Analytics III-69Table 95: Rest of Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-69Table 96: Rest of Asia-Pacific Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-70Table 97: Rest of Asia-Pacific 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-71
6. LATIN AMERICA III-72Market Analysis III-72Table 98: Latin American Recent Past, Current & FutureAnalysis for Cholesterol Testing by Geographic Region -Brazil, and Rest of Latin America Markets IndependentlyAnalyzed with Annual Tests in Thousands for Years 2013through 2020 (includes corresponding Graph/Chart) III-72Table 99: Latin American Historic Review for CholesterolTesting by Geographic Region - Brazil, and Rest of LatinAmerica Markets Independently Analyzed with Annual Tests inThousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-73Table 100: Latin American 15-Year Perspective forCholesterol Testing by Geographic Region - PercentageBreakdown of Tests for Brazil, and Rest of Latin AmericaMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-74
Table 101: Latin American Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-75Table 102: Latin American Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-76Table 103: Latin American 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-77
6a. BRAZIL III-78Market Analysis III-78Table 104: Brazilian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-78Table 105: Brazilian Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-79Table 106: Brazilian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-80
6b. REST OF LATIN AMERICA III-81Market Analysis III-81Table 107: Rest of Latin America Recent Past, Current &Future Analysis for Cholesterol Testing by Test Type - LipidPanel Test/Complete Lipid Profile, Apolipoprotein B, andOther Cholesterol Tests Independently Analyzed with AnnualTests in Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-81Table 108: Rest of Latin America Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-82Table 109: Rest of Latin America 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-83
7. REST OF WORLD III-84Market Analysis III-84Table 110: Rest of World Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-84Table 111: Rest of World Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-85Table 112: Rest of World 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-86
IV. COMPETITIVE LANDSCAPETotal Companies Profiled: 32 (including Divisions/Subsidiaries - 37)The United States (29)Canada (1)Japan (1)Europe (4)- Germany (1)- The United Kingdom (2)- Rest of Europe (1)Asia-Pacific (Excluding Japan) (2)
Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html
About Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com
__________________________Contact Clare: [email protected] US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cholesterol-testing-market-649028559.html
SOURCE Reportlinker
Advertisement
Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3A. Lipid Panel Test/Complete Lipid Profile I-3Total Cholesterol Test I-3HDL Cholesterol Test I-3LDL Cholesterol Testing I-3Triglycerides/VLDL Cholesterol Testing I-4B. Apolipoprotein B I-4C. Other Apolipoprotein Tests I-4
Advertisement
II. EXECUTIVE SUMMARY1. INDUSTRY OVERVIEW II-1Cholesterol Testing - An Overview II-1Current & Future Analysis II-2Increasing Healthcare Expenditure to Promote Testing Market II-2Table 1: Per-Capita Healthcare Expenditure in US$ for SelectRegions (2013) (includes corresponding Graph/Chart) II-3Developing Economies Offer Significant Potential II-3Table 2: Healthcare Spending as Percentage of GDP in SelectDeveloping Countries (2012) (includes correspondingGraph/Chart) II-4Table 3: Healthcare Spending as Percentage of GDP in SelectDeveloped Countries for 2004, 2008 & 2012 (includescorresponding Graph/Chart) II-42. TRENDS, DRIVERS & CHALLENGES II-5Global Menace of Cardiovascular Disease - Major Growth Factor II-5Table 4: Global Annual Medical Cost of CVD in US$ Billion(2010-2030) (includes corresponding Graph/Chart) II-5
Table 5: Fatalities by Heart Conditions - EstimatedPercentage Breakdown for Cardiovascular Disease, IschemicHeart Disease, Stroke, and Others (includes correspondingGraph/Chart) II-5Table 6: Fatalities in Low Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes corresponding Graph/Chart) II-6Table 7: Fatalities in Mid Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes corresponding Graph/Chart) II-7
Table 8: Fatalities in High Income Countries by HealthDisorder (2015 & 2030): Projected Percentage Breakdown ofNumber of Deaths for CVD, Cancer, Injury, and Others(includes corresponding Graph/Chart) II-8Preventive Healthcare Trend to Expand Growth II-8Technological Advances to Improve Cholesterol Testing II-8Cholesterol Testing With Smartphone II-9Growing Smartphone Sales - A Business Case II-9Table 9: Top Ten Countries by Mobile Subscriptions inMillions (2012) (includes corresponding Graph/Chart) II-10Table 10: World Smartphone Market: Sales in Million Units byGeographic Region/Country for 2013 & 2017 (includescorresponding Graph/Chart) II-11Non-Invasive Cholesterol Tests to Drive Demand II-11Digital Photographs to Screen Cholesterol? II-11Miniature Sensors - The Future of Cholesterol Testing II-12Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers II-12The Rise of C-reactive Protein Tests II-13Global In-Vitro Diagnostics Market Signals Prospects II-13Table 11: Global In-Vitro Diagnostics Market by Test Category(2013): Percentage Breakdown of Value Sales for AnatomicPathology, Blood Screen Immunoassay, Coagulation, Hematology,Immunoassay, Microbiology, Molecular Diagnostics,Point-of-Care Diagnostics, and Others (includes correspondingGraph/Chart) II-14
Table 12: Global In-Vitro Diagnostics Market by Sector(2013): Percentage Breakdown of Revenues for Decentralized &Patient Self-Testing, and Hospital & Commercial Laboratories(includes corresponding Graph/Chart) II-15Table 13: Global Market for In-Vitro Diagnostics byGeographic Region (2013): Percentage Share Breakdown of ValueSales for Asia-Pacific (Excl. Japan), EMEA, Japan, LatinAmerica and North America (includes correspondingGraph/Chart) II-15Cardiac IVD Market Offers Potential II-15POC Testing: Potential Opportunities Ahead II-16Complexities in the POC Diagnostics Market II-16Aging Population - A Vital Demography for Cholesterol Testing II-16Table 14: Global Population Statistics for 65+ Age Group(Male & Female) for Major Countries/Regions (2013) (includescorresponding Graph/Chart) II-17
Table 15: Global Life Expectancy at Age 60 and 80 Years -(2010-2015), (2020-2025) & (2045-2050) (includescorresponding Graph/Chart) II-18Risk of CVD in Obesity Offers Prospects for Cholesterol Testing II-18Table 16: Global Obese Population in Millions by Region/Country (2013) (includes corresponding Graph/Chart) II-19Table 17: Global Obesity Levels (2013): Percentage ShareBreakdown of Total Obese Population by Leading Countries(includes corresponding Graph/Chart) II-20Diabetics at Higher Risk of Heart Diseases II-20Table 18: Worldwide Prevalence of Diabetes Mellitus byGeographic Region (2013 & 2035P) (includes correspondingGraph/Chart) II-21The Hypertension-Cholesterol Link to Drive Demand II-21Table 19: Death Rates Due to Hypertension in SelectCountries: 2011 II-22Table 20: Percentage Prevalence Rate of High Blood Pressurefor Patients over 25 Years of Age by Region (1980 & 2010)(includes corresponding Graph/Chart) II-24E-Retailing Drives Demand for Home Test Kits II-24Table 21: Factors Influencing Online Purchase Decision -Percentage Share Breakdown of Consumer Preferences byCriteria (includes corresponding Graph/Chart) II-253. AN INSIGHT INTO CARDIOVASCULAR DISEASES II-26The Heart of Heart Problems II-26Types of Cardiovascular Diseases/Disorders II-26Coronary Artery Disease II-26Hyperlipidemia - An Important Risk Factor of Heart Disease II-26Hypertension - The Silent Killer II-27Two-Pronged Approach to Counter CVD II-28Cardiovascular Risk Assessment II-28Reality Check II-28
4. GOOD & BAD OF CHOLESTEROL II-29Blood Cholesterol - The Principal Cardiac Risk Marker II-29Types of Cholesterol II-29Total Cholesterol (TC) II-29High Density Lipoprotein (HDL) II-29Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein(VLDL) II-30Triglycerides (TRG) II-30Glucose (GLU) II-30Alanine Aminotransferase (ALT) II-30Outcomes of High Blood Cholesterol II-30Atherosclerosis II-30Coronary Heart Disease (CHD) II-30Risk Factors and Risk Levels II-30Risk Factors II-30Risk Levels II-31Risk Level Based on Total Cholesterol Concentration II-31LDL-Cholesterol Risk Levels II-31HDL-Cholesterol Risk Levels II-31Triglyceride Risk Levels II-315. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES II-32Cholesterol Testing II-32Need for Cholesterol Testing II-32Candidates for Cholesterol Testing II-32Test Procedure II-33Time of Testing - Crucial for Heart Disease Patients II-33Types of Cholesterol Testing II-34Lipid Panel Test/Lipid Profile II-34Total Cholesterol Test II-34HDL Cholesterol Test II-35LDL Cholesterol Testing II-35LDL Cholesterol Test - The First Cholesterol Testing Method II-35Triglycerides/VLDL Cholesterol Testing II-36Apolipoprotein B Test II-36Other Cholesterol Tests II-36Apolipoprotein A-1 Test II-36ApoE Genotyping Test II-36Apolipoprotein CII II-36Other Key Markers for Cholesterol Testing II-37RLP Cholesterol II-37Non Instrumented Technologies II-37Heart Disease Diagnosis Tests II-37Non-Invasive Tests II-37Invasive Tests II-38Other CVD Markers II-38Creatine Kinase MB II-38Troponin T and Troponin I II-38Myoglobin II-39P-selectin Profile II-39C-reactive Protein II-39Endothelial Dysfunction II-40Homocysteine II-40Plasminogen Activator Inhibitor-1 II-40s-100 Protein II-41Thrombus Precursor Protein II-41Other Cardiac Markers II-41
6. POINT OF CARE & HOME CHOLESTEROL TESTING II-42Point of Care (POC) Medical Diagnostics II-42Table 22: Global Point of Care Diagnostics Market by Segment(2013): Percentage Breakdown of Revenues for Commercial Labs,Hospital Labs, Point of Care and Self Testing (includescorresponding Graph/Chart) II-42POC Testing Market II-43Table 23: Global Point-of-Care Diagnostics Market by POCTests (2013 & 2015): Percentage Share Breakdown of Revenuesfor Blood Chemistry, Cardiac Markers, Cholesterol, Drug &Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, andOthers (includes corresponding Graph/Chart) II-43Development of Home Cholesterol Testing Kits II-43Cholesterol and Other Cardiovascular Test Kits Offered bySelect Companies II-447. CHOLESTEROL CONTROL & TREATMENT MODALITIES II-45Prevention is better than Cure II-45Dietary Therapy II-45Healthy Diet II-45Exercises II-46Drug Therapy II-46Classification of Cholesterol Lowering Drugs II-46Bile Acid Sequestrants II-46Nicotinic Acid II-46HMG CoA Reductase Inhibitors (Statins) II-47Other Drugs (Fibric Acids and Probucol) II-47Testing After Commencing Drug Therapy II-478. PRODUCT INTRODUCTIONS/INNOVATIONS II-48CODIX Introduces SelexOn™ II-48Health Canada Approves Abbott's ARCHITECT STAT High SensitiveTroponin-I Assay II-48PTS Unveils CardioChek® Plus II-48ACON Introduces Mission® Systems II-48Everist Genomics to Unveil AngioDefender II-48Pathway Genomics Introduces InsightSM II-48Boston Heart Diagnostics Unveils SLCO1B1 Genotype Test II-48diaDexus Unveils PLAC® Test in Europe II-48
9. RECENT INDUSTRY ACTIVITY II-49PTS Switches Name to Chek Diagnostics II-49LipoScience Parts Ways with Health Diagnostics II-49Miraculins and Citizen Doctor Sign Distribution Deal II-49Akers Biosciences Signs Distribution Deal for Rapid Tests inAustralia, Singapore & Middle East II-49ITC Nexus Acquires Accumetrics II-49MedTest Signs Deal to Take Over Pointe Scientific II-49Response Biomedical Signs Deal for Sales Representation withMed Tech/Med Care II-49Corgenix Partners Health Diagnostic Laboratory II-50LipoScience Commences Clinical Development of NMR Diagnostics II-50Harbert Takes Over Cardioscan II-50BG Medicine Signs Deal with Kindstar Diagnostics to OfferGalectin-3 Testing Services II-5010. FOCUS ON SELECT PLAYERS II-51Abbott Diagnostics, Inc. (US) II-51AccuTech, LLC (US) II-51Alere Inc. (US) II-51Beckman Coulter, Inc. (US) II-52Chek Diagnostics (US) II-53F. Hoffmann-La Roche Ltd (Switzerland) II-53Home Access Health Corporation (US) II-54Siemens Healthcare (Germany) II-5411. GLOBAL MARKET PERSPECTIVE II-55Table 24: World Recent Past, Current & Future Analysis forCholesterol Testing by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual Tests inMillions for Years 2013 through 2020 (includes correspondingGraph/Chart) II-55
Table 25: World Historic Review for Cholesterol Testing byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-56Table 26: World 15-Year Perspective for Cholesterol Testing byGeographic Region - Percentage Breakdown of Tests for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) II-57Market by Test Type II-58Table 27: World Recent Past, Current & Future Analysis forLipid Panel/Complete Lipid Profile Tests by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets Independently Analyzedwith Annual Tests in Millions for Years 2013 through 2020(includes corresponding Graph/Chart) II-58Table 28: World Historic Review for Lipid Panel/ CompleteLipid Profile Tests by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual Tests inMillions for Years 2006 through 2012 (includes correspondingGraph/Chart) II-59
Table 29: World 15-Year Perspective for Lipid Panel/CompleteLipid Profile Tests by Geographic Region - PercentageBreakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-60Table 30: World Recent Past, Current & Future Analysis forApolipoprotein B Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualTests in Millions for Years 2013 through 2020 (includescorresponding Graph/Chart) II-61Table 31: World Historic Review for Apolipoprotein B Tests byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-62
Table 32: World 15-Year Perspective for Apolipoprotein B Testsby Geographic Region - Percentage Breakdown of Tests for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) II-63Table 33: World Recent Past, Current & Future Analysis forOther Cholesterol Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualTests in Millions for Years 2013 through 2020 (includescorresponding Graph/Chart) II-64Table 34: World Historic Review for Other Cholesterol Tests byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Tests in Millions for Years2006 through 2012 (includes corresponding Graph/Chart) II-65Table 35: World 15-Year Perspective for Other CholesterolTests by Geographic Region - Percentage Breakdown of Tests forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2006, 2014 &2020 (includes corresponding Graph/Chart) II-66
III. MARKET1. THE UNITED STATES III-1A.Market Analysis III-1Outlook III-1Surge in CVD Incidence - Major Growth Factor III-1Table 36: CVD in the US: Cardiovascular Disease Prevalencein Adults by Gender & Age Group (includes correspondingGraph/Chart) III-1Table 37: CVD in the US: Cardiovascular Disease Incidenceby Gender & Age Group (per 1,000 Adults) (includescorresponding Graph/Chart) III-2Table 38: Leading Causes of CVD Fatalities in the US:Percentage Breakdown of Mortality for Coronary HeartDisease, HBP, Heart Failure, Stroke, and Others (includescorresponding Graph/Chart) III-2Ageing Population - Vital Demography III-2Table 39: North American Elderly Population by Age Group:1975-2050 (includes corresponding Graph/Chart) III-3The Risk of CVD in Chronic Conditions to Drive Testing Market III-3Opportunity Indicators III-4Table 40: Obesity Prevalence in US Adults by Type ofObesity (2013) (includes corresponding Graph/Chart) III-4Table 41: Obesity Prevalence in the US by Age Group (2013)(includes corresponding Graph/Chart) III-4Table 42: Obesity Prevalence in the US by PercentageAnnual Income Level (2013) (includes correspondingGraph/Chart) III-4
Table 43: US Diabetics Population (2010-2017): PercentagePopulation with Diagnosed and Undiagnosed Diabetes(includes corresponding Graph/Chart) III-5Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart) III-5Table 45: High Blood Pressure Prevalence in the US (2012):Prevalence Rates for Male and Female Population by AgeGroups (includes corresponding Graph/Chart) III-6Table 46: High Blood Pressure Prevalence in the US (2012):Prevalence Rates for Male and Female Population by EthnicGroup (includes corresponding Graph/Chart) III-6Increasing Cardiovascular Ailments Drive Sales of Home TestDevices III-7Cholesterol POCT Market: An Overview III-7Cholesterol Testing - NCEP Recommendations Spurs Potential III-7Innovations Drive the Usage of Cardiovascular MonitoringSystems III-7Sterols and Stanols: Cholesterol-Lowering Products III-8Product Launches III-8Strategic Corporate Developments III-9Key Players III-10B.Market Analytics III-13Table 47: US Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-13
Table 48: US Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-14Table 49: US 15-Year Perspective for Cholesterol Testing byTest Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-15
2. CANADA III-16A.Market Analysis III-16Outlook III-16Product Launch III-16B.Market Analytics III-17Table 50: Canadian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-17Table 51: Canadian Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-18Table 52: Canadian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-19
3. JAPAN III-20Market Analysis III-20Table 53: Japanese Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-20Table 54: Japanese Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-21Table 55: Japanese 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-22
4. EUROPE III-23A.Market Analysis III-23Outlook III-23Product Launch III-23B.Market Analytics III-24Table 56: European Recent Past, Current & Future Analysisfor Cholesterol Testing by Geographic Region - France,Germany, Italy, UK, Spain, Russia, and Rest of EuropeMarkets Independently Analyzed with Annual Tests inThousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-24Table 57: European Historic Review for Cholesterol Testingby Geographic Region - France, Germany, Italy, UK, Spain,Russia, and Rest of Europe Markets Independently Analyzedwith Annual Tests in Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-25Table 58: European 15-Year Perspective for CholesterolTesting by Geographic Region - Percentage Breakdown of Testsfor France, Germany, Italy, UK, Spain, Russia, and Rest ofEurope Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-26
Table 59: European Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-27Table 60: European Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-28Table 61: European 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-29
4a. FRANCE III-30Market Analysis III-30Table 62: French Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-30Table 63: French Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-31Table 64: French 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-32
4b. GERMANY III-33A.Market Analysis III-33Outlook III-33Siemens Healthcare - Key German Player III-33B.Market Analytics III-34Table 65: German Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-34Table 66: German Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-35Table 67: German 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-36
4c. ITALY III-37Market Analysis III-37Table 68: Italian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-37Table 69: Italian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-38Table 70: Italian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-39
4d. THE UNITED KINGDOM III-40Market Analysis III-40Table 71: UK Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-40Table 72: UK Historic Review for Cholesterol Testing by TestType - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-41Table 73: UK 15-Year Perspective for Cholesterol Testing byTest Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-42
4e. SPAIN III-43Market Analysis III-43Table 74: Spanish Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-43Table 75: Spanish Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-44Table 76: Spanish 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-45
4f. RUSSIA III-46Market Analysis III-46Table 77: Russian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-46Table 78: Russian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-47Table 79: Russian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/ Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-48
4g. REST OF EUROPE III-49A.Market Analysis III-49Outlook III-49Product Launch III-49F. Hoffmann-La Roche Ltd. - A Key Swiss Player III-49B.Market Analytics III-50Table 80: Rest of Europe Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-50Table 81: Rest of Europe Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-51Table 82: Rest of Europe 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-52
5. ASIA-PACIFIC III-53A.Market Analysis III-53The Largest Market Worldwide III-53B.Market Analytics III-54Table 83: Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Geographic Region -China, India, and Rest of Asia-Pacific Markets IndependentlyAnalyzed with Annual Tests in Thousands for Years 2013through 2020 (includes corresponding Graph/Chart) III-54Table 84: Asia-Pacific Historic Review for CholesterolTesting by Geographic Region - China, India, and Rest ofAsia-Pacific Markets Independently Analyzed with AnnualTests in Thousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-55Table 85: Asia-Pacific 15-Year Perspective for CholesterolTesting by Geographic Region - Percentage Breakdown of Testsfor China, India, and Rest of Asia-Pacific Markets for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-56Table 86: Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-57
Table 87: Asia-Pacific Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-58Table 88: Asia-Pacific 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-59
5a. CHINA III-60A.Market Analysis III-60Outlook III-60Corporate Development III-60B.Market Analytics III-61Table 89: Chinese Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-61Table 90: Chinese Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-62Table 91: Chinese 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-63
5b. INDIA III-64A.Market Analysis III-64Outlook III-64Corporate Development III-64B.Market Analytics III-65Table 92: Indian Recent Past, Current & Future Analysis forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-65Table 93: Indian Historic Review for Cholesterol Testing byTest Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-66Table 94: Indian 15-Year Perspective for Cholesterol Testingby Test Type - Percentage Breakdown of Tests for Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-67
5c. REST OF ASIA-PACIFIC III-68A.Market Analysis III-68Outlook III-68Corporate Development III-68B.Market Analytics III-69Table 95: Rest of Asia-Pacific Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-69Table 96: Rest of Asia-Pacific Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-70Table 97: Rest of Asia-Pacific 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-71
6. LATIN AMERICA III-72Market Analysis III-72Table 98: Latin American Recent Past, Current & FutureAnalysis for Cholesterol Testing by Geographic Region -Brazil, and Rest of Latin America Markets IndependentlyAnalyzed with Annual Tests in Thousands for Years 2013through 2020 (includes corresponding Graph/Chart) III-72Table 99: Latin American Historic Review for CholesterolTesting by Geographic Region - Brazil, and Rest of LatinAmerica Markets Independently Analyzed with Annual Tests inThousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-73Table 100: Latin American 15-Year Perspective forCholesterol Testing by Geographic Region - PercentageBreakdown of Tests for Brazil, and Rest of Latin AmericaMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-74
Table 101: Latin American Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-75Table 102: Latin American Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-76Table 103: Latin American 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-77
6a. BRAZIL III-78Market Analysis III-78Table 104: Brazilian Recent Past, Current & Future Analysisfor Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-78Table 105: Brazilian Historic Review for Cholesterol Testingby Test Type - Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests IndependentlyAnalyzed with Annual Tests in Thousands for Years 2006through 2012 (includes corresponding Graph/Chart) III-79Table 106: Brazilian 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-80
6b. REST OF LATIN AMERICA III-81Market Analysis III-81Table 107: Rest of Latin America Recent Past, Current &Future Analysis for Cholesterol Testing by Test Type - LipidPanel Test/Complete Lipid Profile, Apolipoprotein B, andOther Cholesterol Tests Independently Analyzed with AnnualTests in Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-81Table 108: Rest of Latin America Historic Review forCholesterol Testing by Test Type - Lipid Panel Test/CompleteLipid Profile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-82Table 109: Rest of Latin America 15-Year Perspective forCholesterol Testing by Test Type - Percentage Breakdown ofTests for Lipid Panel Test/Complete Lipid Profile,Apolipoprotein B, and Other Cholesterol Tests for Years2006, 2014 & 2020 (includes corresponding Graph/Chart) III-83
7. REST OF WORLD III-84Market Analysis III-84Table 110: Rest of World Recent Past, Current & FutureAnalysis for Cholesterol Testing by Test Type - Lipid PanelTest/Complete Lipid Profile, Apolipoprotein B, and OtherCholesterol Tests Independently Analyzed with Annual Testsin Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-84Table 111: Rest of World Historic Review for CholesterolTesting by Test Type - Lipid Panel Test/Complete LipidProfile, Apolipoprotein B, and Other Cholesterol TestsIndependently Analyzed with Annual Tests in Thousands forYears 2006 through 2012 (includes corresponding Graph/Chart) III-85Table 112: Rest of World 15-Year Perspective for CholesterolTesting by Test Type - Percentage Breakdown of Tests forLipid Panel Test/Complete Lipid Profile, Apolipoprotein B,and Other Cholesterol Tests for Years 2006, 2014 & 2020(includes corresponding Graph/Chart) III-86
IV. COMPETITIVE LANDSCAPETotal Companies Profiled: 32 (including Divisions/Subsidiaries - 37)The United States (29)Canada (1)Japan (1)Europe (4)- Germany (1)- The United Kingdom (2)- Rest of Europe (1)Asia-Pacific (Excluding Japan) (2)
Read the full report: http://www.reportlinker.com/p02438209-summary/view-report.html
About Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com
__________________________Contact Clare: [email protected] US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cholesterol-testing-market-649028559.html
SOURCE Reportlinker
